ArticleCardiology research2025
Evaluation of Gold Marker Orientation in the Three-Cusp Coplanar View After Evolut FX Transcatheter Aortic Valve Implantation.
Article in Cardiology research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Obtaining commissural alignment in transcatheter aortic valve replacement (TAVR) is important for ensuring coronary access and coronary artery filling, reducing the risk of central leaks, and minimizing leaflet stress. The Evolut FX system has the gold markers placed at the neo-commissures and has demonstrated favorable outcomes. We investigated whether evaluating the orientation of the gold markers in a three-cusp coplanar view (3-CV) after Evolut FX implantation was useful for assessing commissural misalignment (CMA). Methods: Between April 2023 and December 2024, we included 25 patients who underwent transfemoral TAVR using the Evolut FX for symptomatic severe aortic stenosis. All patients underwent multidetector computed tomography (CT) after TAVR. The native-prosthetic gap (NPG) was defined as the distance between the center of the transcatheter heart valve stent frame and the central gold marker in a 3-CV. We evaluated the association between the NPG and CMA, which was derived from the average misalignment deviation on post-TAVR CT. Results: The median age was 84 years, 36% were male, and 8% had coronary artery disease. The implanting view was the cusp overlap view (COV) in 11 patients, the near-COV in 11 patients, and the left anterior oblique view in three patients. Of the 22 patients implanted using the COV or near-COV, the gold markers were positioned at "2 left-1 right" in 17 patients. The average misalignment deviation was 18.0° (commissural alignment: eight patients, mild CMA: 13 patients, moderate CMA: two patients, and severe CMA: two patients) and the median NPG was 0.11. In cases with commissural alignment and mild CMA, NPG showed a significant positive correlation with the average misalignment deviation (r = 0.68, P < 0.01), whereas in cases with moderate and severe CMA, the relationship was inverse (r = -0.38, P = 0.62). Further, in cases with commissural alignment and mild CMA, a clockwise misalignment occurred when the central marker was positioned closer to the non-coronary cusp side, while a counterclockwise misalignment was observed when positioned closer to the left-coronary cusp side. Conclusions: Evaluating the orientation of the gold markers in a 3-CV after Evolut FX implantation is useful for assessing CMA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.